Chemoradiotherapy for lung cancer

Kuniaki Katsui

Research output: Contribution to journalArticlepeer-review


Lung cancer remains a disease associated with a poor prognosis. Chemoradiotherapy is performed for unresectable stage III non-small cell lung cancer (NSCLC) and inoperable limited-disease small cell lung cancer. In this lecture, chemoradiotherapy for lung cancer is outlined primarily according to the 2014 edition of the Clinical Practice Guidelines for Lung Cancer, and also referring to molecular targeted drugs, radiation pneumonitis, and particle radiotherapy.

Original languageEnglish
Pages (from-to)1129-1138
Number of pages10
JournalJapanese Journal of Clinical Radiology
Issue number9
Publication statusPublished - 2015

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Chemoradiotherapy for lung cancer'. Together they form a unique fingerprint.

Cite this